C1166 variant of the angiotensin II receptor type 1 gene and myocardial infarction - Risk factor or a chance of survival?

Kardiologia Polska

Volumn 56, Issue 2, 2002, Pages 138-142

  Dzida, Grzegorz ^a   Galeziok, Michal ^a   Kraczkowski, Tomasz ^a   Sobstyl, Jacek ^a   Golon Siekierska, Patrycja ^a   Puźniak, Andrzej ^a   Bilan, Andrzej ^a   Mosiewicz, Jerzy ^a   Hanzlik, Janusz ^a  

^a Pneumonologii i Alergologii Akademii Medycznej w Warszawie   (Poland)

Author keywords

Angiotensin II type 1 receptor; Genetic polymorphism; Myocardial infarction

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POLAND; RISK FACTOR;

EID: 0036198489     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. 4 receptors
2. Cloning and characterisation of a human angiotensin II type 1 receptor
3. Evaluation of three polymorphisms in the promoter region of the angiotensin II type 1 receptor gene
4. Characterization of polymorphisms in the promoter of the human angiotensin II type 1 receptor gene
5. New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: File the ECTIM study
6. DNA banking: The effect of storage of blood and isolated DNA on the integrity of DNA
7. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension
8. Association of angiotensin II type receptor type 1 gene polymorphism with essential hypertension
9. A polymorphisms in the gene for the angiotensin II type 1 receptor is not associated with hypertension
10. Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension
11. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy
12. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: Association with early coronary disease
13. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on risk of myocardial infarction
14. Angiotensin II type 1 receptor gene polymorphism is associated with the severity but not prevalence of coronary artery disease
15. Genetic polymorphisms and coronary artery disease in the south of France
16. Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of synergistic effect with angiotensin-converting enzyme gene polymorphisms on the risk of these diseases
17. Angiotensin II type 1-receptor and ACE polymorphisms and risk of myocardial infarction in men and women
18. Acute myocardial infarction in young adults: Prognostic role of angiotensin-converting enzyme, angiotensin II type 1 receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase and glycoprotein IIIa genetic polymorphisms at medium-term follow-up
19. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction
20. Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolaemia
21. Vascular and haemostatic gene polymorphisms associated with non-fatal myocardial infarction: A critical review
22. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias
23. Angiotensin II type 1A receptor knockout mice display less left ventricular remodelling and improved survival after myocardial infarction
24. Surviving infarction one gene at a time: Decreased remodelling and mortality in engineered mice lacking the angiotensin II type 1A receptor
25. Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease
26. Analysis of the postulated interaction between A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin converting gene on risk of myocardial infarction
27. Genetic polymorphism in the renin-angiotensin system: Relevance for susceptibility to cardiovascular disease
28. Searching for the better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms
29. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II
30. Analysis of the postulated interaction between A1166C polymorphism and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on risk of myocardial infarction
31. Genetic polymorphisms in the renin-angiotensis system: Relevance for susceptibility to cardiovascular disease
32. Searching for the better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms
33. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II